Coronavirus: In Mumbai, BMC receives 99,000 doses of Covishield vaccine

The BMC on Saturday said it received 99,000 doses of the Covishield vaccine

Covishield
Covishield coronavirus vaccine | Photo: PTI
ANI General News
2 min read Last Updated : Apr 10 2021 | 7:39 PM IST

The Brihanmumbai Municipal Corporation (BMC) on Saturday said it received 99,000 doses of the Covishield vaccine.

As per the BMC, the doses will be distributed to civic and government-run vaccine centres.

Vaccine shortage in Mumbai led to the temporary halting of vaccination across 75 vaccination centres in the city on Friday.

This comes amid allegations by Chief Ministers across the country that there are only enough vaccines in the state for the next few days.

Mumbai is currently under a weekend lockdown till 7 am on Monday in an effort to curb the spread of the COVID-19 infection. The city reported 9,200 COVID19 cases and 35 deaths on Friday. There are currently 90,333 active cases in the city.

Earlier, Maharashtra Cabinet Minister Aslam Shaikh had said that Maharashtra received the least number of vaccines and a majority of vaccination centres were facing closure due to shortage of doses.

"Centre is doing politics. Earlier more vaccinations centres were opened and we were told to vaccinate more and more people but later they stopped giving us the vaccines. Maharashtra has received the least number of vaccine doses. Today, a majority of vaccination centres across the state have been shut due to shortage of vaccine," he told reporters.

Earlier in the day, Maharashtra Chief Minister Uddhav Thackeray called an all-party meeting via video conference to review the current COVID-19 situation in the state.

Maharashtra on Friday recorded 58,993 new COVID-19 cases, 45,391 recoveries, and 301 deaths.

The Maharashtra government has also imposed a strict weekend lockdown from Friday night till 7 am on Monday. The home delivery of food and essential supplies and movement of students taking various exams are allowed.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 10 2021 | 7:37 PM IST

Next Story